Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025)

Zentalis Pharmaceuticals (ZNTL) recorded quarterly Restructuring Costs of $7.8 million in Q1 2025.

Zentalis Pharmaceuticals (ZNTL) Restructuring Costs (2025) Analysis & Trends

Zentalis Pharmaceuticals' Restructuring Costs history runs 1 years deep, the most recent figure standing at $7.8 million for Q1 2025.

In Q1 2025, Restructuring Costs changed N/A year-over-year to $7.8 million; the TTM figure through Dec 2025 stood at $7.8 million (changed N/A YoY), while the FY2025 annual figure was $7.8 million, changed N/A from the prior year.
Restructuring Costs was $7.8 million for Q1 2025 at Zentalis Pharmaceuticals.
In the past five years, Restructuring Costs ranged from a high of $7.8 million in Q1 2025 to a low of $7.8 million in Q1 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Zentalis Pharmaceuticals	260.33 Mn	260.33 Mn	-

Historic Data

Download Data

Date	Value
Mar 31, 2025	7.80 Mn